Company: RPTX
Filing Date: 2025-12-03
Form Type: PREM14A
Source: 0001193125-25-306948
Chunk: 147

Company: Repare Therapeutics Inc.
Filing Date: 2025-12-03
Form: PREM14A
Chunk 147
---
ET POLICY AND DIVIDEND DATA

The Common Shares currently trade on Nasdaq under the ticker symbol “RPTX.” On November 28, 2025, the last full trading day
prior to the date of this Circular and Proxy Statement, the reported closing price of the Common Shares on Nasdaq was $2.18 per Share.Shareholders are urged to obtain a current market quotation for the Common Shares.

We have not declared or paid any cash dividends on our share capital since our formation and we intend to retain future earnings, if any, for
use of the operation of our business, and not currently intend to pay any cash dividends in the foreseeable future.

90

SECURITY OWNERSHIP OF CERTAIN BENEFICIAL OWNERS AND MANAGEMENT The following table sets forth information as of the Record Date, regarding the beneficial ownership of Common Shares by (i) each Person we know to be the beneficial owner of 5% or more of Common Shares, (ii) each of our current executive officers, (iii) each of our directors and (iv) all of our current executive officers and directors as a group. Information with respect to beneficial ownership has been furnished by each director, executive officer or 5% or more Shareholder, as the case may be. Percentage of beneficial ownership is calculated based on 43,108,362 Common Shares outstanding as of the Record Date. Beneficial ownership is determined in accordance with the rules of the SEC which generally attribute beneficial ownership of securities to Persons who possess sole or shared voting power or investment power with respect to those securities and includes Common Shares issuable pursuant to the exercise of Options or other securities that are immediately exercisable or convertible or exercisable or convertible within 60 days of the Record Date. Unless otherwise indicated, the Persons or entities identified in this table have sole voting and investment power with respect to all Common Shares shown as beneficially owned by them. Unless otherwise noted, the address for each Person set forth on the table below is c/o Repare Therapeutics Inc., 7171 Frederick-Banting, Building 2, Suite 270, St-Laurent,Québec, Canada.

|                                                              |     | Beneficial Ownership (1) |            |     |     |                      |      |   |
| Name of Beneficial Owner                                     |     | Common Shares            
 Beneficially             
 Owned                    |            |     |     | Percentage of Common 
 Shares Beneficially  
 Owned (%)            |      |   |
| 5% Shareholder:                                              |